Delivery Order SPE2DB20D1109-SPE2DB21FP86Y
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,168.50 delivery order contract is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,318.80 firm fixed price delivery order is for the supply of 4,566,490,689 units of Imitrex 6 mg/0.5 ml cartridges. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,747.95 Firm Fixed Price Delivery Order is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML medical products. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,495.61 for the supply of Imitrex 6 mg/0.5 ml cartridges. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Imitrex 6 mg/0.5 ml cartridges (0.5 ml) to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,811.21, has a completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.19 delivery order is for IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has a firm fixed price and is set to expire on July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The contract, valued at $4,857.20, is a firm fixed-price delivery order with a completion date of November 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML to the Defense Logistics Agency (DLA). The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price of $24,032.26 and an ultimate completion date of May 22, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a prescription medication. The contract, valued at $6,278.68, was awarded by the Defense Logistics Agency (DLA) on July 11, 2024 with a completion date of July 12, 2024. The contract is a firm fixed price delivery order with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a single-award Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,227.63 firm-fixed-price delivery order is for the provision of Imitrex 6 mg/0.5 ml cartridges. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract (IDC) valued up to...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB21FP86YDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,069.44 firm fixed-price delivery order is for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has an ultimate completion date of August 26, 2021. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale. The contract award was made through full and open competition without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 8/25/21 |